Beijing [China], August 05 (ANI/Sputnik): Around 50,000 people in a number of countries are participating in phase 3 clinical trials of a coronavirus vaccine developed by the China National Biotec Group (CNBG), the company said on Saturday in a press release.
Beijing [China], June 9 (ANI): China's inactivated COVID-19 vaccine has shown protection against coronavirus infection in animal experiments, Xinhua reported citing a study published in the journal Cell.